Dishman Carbogen Amcis Limited

Web: dishmangroup.com NSE: DCAL BSE: 540701 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

173 1(-1%)

Volume

6L as on 23, Jun

Open

269

High

274

Low

267

174

VWAP

175

52 Week High

322

52 Week Low

128

Viand Research Rating

Quality Score

5/100

Growth Score

28/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

2,720

No. of Shares

15.7

P/E

-96.2

P/B

0.92

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

-0.95

ROCE

Profit Growth

Listing Date

21-Sep-17

Promoter Holding

59.32%

FII Holding

6.86%

DII Holding

2.06%

Price Chart

Price Performance

1 Week2%

1 Month11%

3 Months21%

6 Months5%

1 Year5%

YTD5%

Moving Average

5 Day SMA171

10 Day SMA175

20 Day SMA185

30 Day SMA187

50 Day SMA183

61 Day SMA176

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	179	174	177	179
Resistance 2	177	174	176	177
Resistance 1	175	173	175	175
Pivot Point	173	173	173	173
Support 1	171	173	172	171
Support 2	170	172	171	170
Support 3	168	172	170	168

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,271	1895	5%	3%	5%	20%	37	57.7	0.07	11509
2	DIVISLAB	2,46,156	9272	2%	13%	47%	55%	69	57.7	0	2568
3	TORNTPHARM	1,86,509	4904	3%	0%	14%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,26,078	8760	2%	2%	13%	13%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,13,576	1139	0%	4%	27%	15%	20	57.7	0.31	3560
6	CIPLA	1,11,872	1395	1%	5%	6%	9%	22	57.7	0.02	3862
7	LAURUSLABS	1,00,336	1857	2%	2%	83%	110%	0	57.7	0.48	890
8	LUPIN	96,762	2116	4%	11%	10%	8%	23	57.7	0.29	5355
9	DRREDDY	96,545	1144	1%	2%	12%	9%	20	57.7	0.2	4158
10	MANKIND	95,885	2322	4%	6%	6%	10%	49	57.7	0.39	1938
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 59.32%	(0.01) 59.32%	(0.01) 59.32%	(0.01) 59.32%	(0.01) 59.32%	(0.01) 59.32%	(0.01) 59.32%	(0.01) 59.32%	(0.01) 59.32%	(0.01) 59.32%	(0.01) 59.32%	(0.01) 59.32%	(0.01) 59.32%	(0.01) 59.32%	(0.01) 59.32%	(0.01) 59.32%	(0.01) 59.32%	(0.01) 59.32%	(0.01) 59.32%	(0.01) 59.32%
FIIs	(-0.61) 6.86%	(-0.21) 7.45%	(-0.41) 7.66%	(-1.91) 8.07%	(0.41) 9.94%	(0.71) 9.49%	(0.61) 8.75%	(0.11) 8.18%	(-0.61) 8.05%	(0.11) 8.70%	(-0.21) 8.60%	(-0.11) 8.80%	(-0.41) 8.90%	(2.11) 9.34%	(1.01) 7.20%	(0.41) 6.20%	(0.41) 5.85%	(0.91) 5.50%	(0.21) 4.60%	(0.01) 4.40%
DIIs	(0.41) 2.06%	(0.41) 1.63%	(-0.11) 1.27%	(0.11) 1.37%	(0.01) 1.27%	(-0.21) 1.26%	(0.21) 1.42%	(-0.31) 1.22%	(-0.91) 1.47%	(-1.31) 2.36%	(0.21) 3.68%	(0.41) 3.51%	(0.61) 3.13%	(-1.31) 2.55%	(-0.41) 3.86%	(-2.41) 4.26%	(-0.31) 6.63%	(0.61) 6.91%	(0.21) 6.31%	(0.01) 6.15%
Public	31.76%	31.60%	31.75%	31.23%	29.48%	29.94%	30.51%	31.29%	31.17%	29.63%	28.39%	28.37%	28.65%	28.79%	29.61%	30.22%	28.19%	28.26%	29.77%	30.13%
No. of Shareholders	49,430	49,009	48,481	49,455	49,744	50,757	52,822	55,280	53,683	50,656	52,336	56,272	56,221	56,583	61,175	59,654	56,986	56,322	54,662	60,726

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	678	851	720	653	708	716	682	789	524	655	651	587	723	619	640	614	541	569	562.08	459	551
Sales Growth % (YoY)	-4.3%	18.8%	5.5%	-17.3%	35.2%	9.4%	4.8%	34.5%	-27.6%	5.8%	1.8%	-4.5%	33.8%	8.7%	13.8%	33.8%	-1.8%	7.5%	20%	4.4%	16.1%
Sales Growth % (QoQ)	-20.3%	18.2%	10.3%	-7.8%	-1.1%	5%	-13.6%	50.6%	-20%	0.6%	10.9%	-18.8%	16.8%	-3.3%	4.2%	13.5%	-4.9%	1.2%	22.5%	-16.7%	-
Expenses	618	688	607	504	567	564	542	642	495	592	610	526	602	567	526	535	452	547	452.58	360	450
Operating Profit	60	163	113	149	141	153	140	147	29	63	41	61	122	51	114	79	88	22	109.5	99	101
OPM %	9	19	16	23	20	21	21	19	6	10	6	10	17	8	18	13	16	4	19.48	22	18
Other Income	16	15	7	8	22	-4	8	4	-4	4	6	5	7	-39	4	9	6	-8	19.04	7	10
Interest	37	43	46	42	43	42	49	37	32	31	33	27	28	24	22	20	19	16	15.11	14	12
Depreciation	91	89	84	84	81	79	72	72	71	85	80	75	70	76	50	80	75	84	74.95	74	75
Profit before tax	-51	46	-10	31	39	28	27	42	-78	-49	-66	-36	29	-88	46	-12	0	-85	38.48	19	24
Tax %	13	53	24	-114	39	-56	83	21	0	42	-10	13	42	-19	-3	-18	-1437	-48	8.06	40	33
Net Profit	-58	22	-13	65	23	43	5	33	-78	-70	-60	-41	17	-71	47	-10	4	-45	35.38	11	16
Net Profit Growth % (QoQ)	-363.6%	269.2%	-120%	182.6%	-46.5%	760%	-84.8%	142.3%	-11.4%	-16.7%	-46.3%	-341.2%	123.9%	-251.1%	570%	-350%	108.9%	-227.2%	221.6%	-31.2%	-
Net Profit Growth % (YoY)	-352.2%	-48.8%	-360%	97%	129.5%	161.4%	108.3%	180.5%	-558.8%	1.4%	-227.7%	-310%	325%	-57.8%	32.8%	-190.9%	-75%	-	-	-	-
TTM Net Profit	16	97	118	136	104	3	-110	-175	-249	-154	-155	-48	-17	-30	-4	-15.62	5.38	17.38	62.38	27	0
EPS in Rs	-3.69	1.39	-0.83	4.16	1.49	2.75	0.3	2.11	-4.95	-4.46	-3.8	-2.61	1.08	-4.51	3	-0.64	0.26	-2.85	2.26	0.71	1.02

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2011
Sales	2932	2712	2616	2413	2141	1912	2044	2059	1695	1714	1031
Sales Growth %	8.1%	3.7%	8.4%	12.7%	12%	-6.4%	-0.7%	21.5%	-1.1%	-	-
Expenses	2366	2243	2329	2081	1809	1638	1540	1507	1249	1261	830
Operating Profit	566	469	286	332	331	274	503	552	445	452	201
OPM %	19	17	11	14	15	14	25	27	26	26	20
Other Income	52	4	22	-20	29	16	39	54	46	26	14
Interest	174	159	120	86	57	48	62	57	49	49	56
Depreciation	339	294	311	281	308	308	283	240	211	214	69
Profit before tax	105	19	-122	-55	-4	-65	197	309	231	216	91
Tax %	7	83	26	-45	-524	154	20	32	33	33	12
Net Profit	97	3	-153	-30	18	-165	159	210	155	145	80
Net Profit Growth %	3133.3%	102%	-410%	-266.7%	110.9%	-203.8%	-24.3%	35.5%	6.9%	81.2%	-
EPS in Rs	6.22	0.21	-9.79	-1.9	1.15	-10.53	10.1	13.03	9.58	0	0
Dividend Payout %	0	0	0	0	0	0	0	2	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2011
Cash from Operating Activity	491	375	379	266	355	513	585	282	226	303	203
Cash from Investing Activity	-245	-196	-225	-494	-619	-380	-442	-169	-297	-107	-231
Cash from Financing Activity	201	-102	-22	250	130	-11	-98	-102	78	-137	25
Net Cash Flow	447	77	132	22	-133	122	46	11	7	59	-3

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2011
Equity Capital	31	31	31	31	31	31	31	31	31	32	32	0	16
Reserves	6646	6334	5800	5705	5596	5778	5518	5667	5684	5347	5075	4814	863
Borrowings	3076	2559	2389	2507	2313	2209	1830	1589	1357	1042	1095	950	868
Other Liabilities	2170	2185	1766	1937	1631	1421	1255	1068	1121	899	967	811	334
Total Liabilities	11923	11109	9987	10180	9571	9439	8634	8356	8193	7321	7169	6574	2081
Fixed Assets	8371	7954	7055	7159	6724	6188	5773	5698	5678	5098	5066	4852	1012
CWIP	275	309	467	580	646	1043	780	486	234	175	151	133	307
Investments	91	91	97	104	102	249	324	172	191	167	196	40	1
Other Assets	3186	2756	2368	2338	2098	1959	1758	2000	2091	1881	1757	1550	761
Total Assets	11923	11109	9987	10180	9571	9439	8634	8356	8193	7321	7169	6574	2081

Delivery

Delivery Data: DCAL

#	Date	167 22% 204	Value (Cr)	Q/T 79	Del 48	Del 11
1	7-Sep	172	2	60	57	1
2	4-Sep	174	2	55	60	1
3	3-Sep	177	2	54	43	1
4	2-Sep	177	4	56	45	2
5	1-Sep	182	11	54	22	2
6	31-Aug	178	12	123	65	8
7	28-Aug	175	4	104	73	3
8	27-Aug	177	4	103	67	3
9	26-Aug	175	7	118	56	4
10	25-Aug	172	3	60	52	2
11	24-Aug	173	4	54	44	2
12	21-Aug	174	9	61	33	3
13	20-Aug	172	6	63	42	3
14	19-Aug	172	6	69	49	3
15	18-Aug	169	9	61	55	5
16	17-Aug	176	45	96	46	20
17	14-Aug	191	4	44	64	3
18	13-Aug	198	13	48	39	5
19	12-Aug	191	4	53	60	3
20	11-Aug	193	4	46	55	2
21	10-Aug	188	4	42	54	2
22	7-Aug	193	2	38	55	1
23	6-Aug	195	4	46	62	3
24	5-Aug	195	10	59	53	5
25	4-Aug	188	2	35	52	1
26	3-Aug	188	2	38	54	1
27	31-Jul	187	1	41	49	1
28	30-Jul	185	3	48	57	2
29	29-Jul	188	4	67	54	2
30	28-Jul	182	1	38	51	1
31	27-Jul	186	4	39	49	2
32	24-Jul	184	2	38	50	1
33	23-Jul	179	5	59	51	2
34	22-Jul	186	3	42	52	2
35	21-Jul	190	3	53	52	1
36	20-Jul	191	2	39	54	1
37	17-Jul	191	5	87	59	3
38	16-Jul	194	2	49	57	1
39	15-Jul	193	9	56	42	4
40	14-Jul	195	4	57	53	2
41	13-Jul	197	5	55	57	3
42	10-Jul	196	7	53	48	3
43	9-Jul	193	7	58	43	3
44	8-Jul	191	9	59	41	4
45	7-Jul	198	12	69	38	5
46	6-Jul	196	9	91	63	5
47	3-Jul	197	36	72	39	14
48	2-Jul	188	19	59	35	6
49	1-Jul	176	5	59	40	2
50	30-Jun	175	8	59	45	3

Daily Market Cap

Date	Total Market Cap	Change	Chg %
07-Sep	2,720c	15c	0.56
04-Sep	2,735c	40c	1.42
03-Sep	2,775c	3c	0.09
01-Sep	2,777c	18c	0.64
31-Aug	2,760c	63c	2.32
25-Aug	2,697c	15c	0.56
24-Aug	2,712c	104c	3.70
21-Aug	2,817c	132c	4.91
19-Aug	2,685c	46c	1.75
18-Aug	2,639c	135c	4.86
17-Aug	2,774c	245c	8.10
14-Aug	3,018c	8c	0.26
13-Aug	3,010c	20c	0.66
12-Aug	2,991c	29c	0.97
11-Aug	3,020c	6c	0.19
10-Aug	3,025c	21c	0.68
07-Aug	3,005c	84c	2.72
06-Aug	3,089c	165c	5.65
04-Aug	2,924c	3c	0.09
31-Jul	2,921c	11c	0.37
30-Jul	2,910c	3c	0.12
29-Jul	2,907c	69c	2.43
28-Jul	2,838c	0	0

Stock Checklist

Price is above from 52 week high low average: 23%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 6 fund scheme(s) across 3 fund house(s) as of Aug26 · Total value ₹83 Cr · 2 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
HSBC Mutual Fund	2	0.73%	+0.09%	82.8
Bandhan Mutual Fund	2	0.10%	-0.01%	0
Motilal Oswal Mutual Fund	2	0.00%	-	0

Dishman Carbogen Amcis Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements